Welcome to LookChem.com Sign In|Join Free
  • or
2-(4-phenylpiperidin-1-yl)benzaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

890127-29-4

Post Buying Request

890127-29-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

890127-29-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 890127-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,1,2 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 890127-29:
(8*8)+(7*9)+(6*0)+(5*1)+(4*2)+(3*7)+(2*2)+(1*9)=174
174 % 10 = 4
So 890127-29-4 is a valid CAS Registry Number.

890127-29-4Relevant academic research and scientific papers

Stereoselective synthesis of spirofused 3-substituted 2,3,4,4a,5,6- hexahydro-6H-benzo[c]quinolizine using the tert-amino effect

Deeva, Elisaveta V.,Glukhareva, Tatiana V.,Tkachev, Alexey V.,Morzherin, Yury Yu.

, p. 82 - 83 (2006)

The interaction of 2-(4-R-piperidino)benzaldehyde and cyclic CH-active compounds occurred as a tandem of Kn?venagel condensation and cyclization by tert-amino effect and led to spiro-fused 3-substituted 2,3,4,4a,5,6- hexahydro-6H-benzo[c]quinolizine.

Benzyl piperazine urea TRPV1 antagonistic and MOR agonistic double-target drug as well as preparation method and application thereof

-

Paragraph 0091-0095, (2021/08/25)

The invention belongs to the technical field of pharmacy, and particularly discloses a benzyl piperazine urea TRPV1 antagonistic and MOR agonistic double-target drug and a preparation method and application thereof, and particularly relates to a compound in general formula (I) and a pharmaceutically acceptable salt thereof, which can be used for preventing and/or treating diseases related to TRPV1 and/or MOR activity. , Immune dysfunction, neurological and psychiatric disorders, respiratory diseases, urinary and reproductive disorders. The invention also relates to a preparation method of the compounds and a pharmaceutical preparation containing the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 890127-29-4